Clinical Evaluation of Vishtindukadi Vati and Mansayadi Kwath Along With Abhyang In Management of Opium Addiction

Clinical Evaluation Of Vishtindukadi Vati & Mansayadi Kwatha alongwith Abhyang in the Management of opium (papaver somniferum linn.)addiction

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048153

Enrollment

100

Registered

2022-12-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F112- Opioid dependence

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed patients of opium addiction. 2.Age between 20-50 years. 3.Patient willing to give consent for clinical trial. 4.Patient of either sex.

Exclusion criteria

Exclusion criteria: 1.opium addicted patients who are suffering from major psychiatric disorder.opium addicted patients suffering from major systemic illness like myocardial infarction,ischemic heart disease,hypertension,HIV,cancer,liver failure and renal toxicity. 2.patient undergoing any other drug therapy. 3.pregnant woman.

Design outcomes

Primary

Measure	Time frame
To evaluate the clinical efficacy of vishtindukadi vati & mansayadi kwatha along with Abhyang in the management of opium addictionTimepoint: 21 days	—

Secondary

Measure	Time frame
To evaluate the clinical efficacy of vishtindukadi vati & mansayadi kwatha alongwith Abhyang in the management of opium addictionTimepoint: 21 days Changes in sign and symptoms will be Recorded	—

Countries

India

Contacts

Public ContactDr Ritu Kapoor

University Post Graduate Institute Of Ayurved Studies and Research

chandan_singh4@yahoo.com9950156020

Outcome results